
Symbiotec Pharmalab IPO
ClosedMainboardIPO Details
IPO Details
Key terms of the offer — price band, lot size, issue size, and important IPO dates.
Issue price₹938-988 per equity share
Lot size15 shares
Face value₹2 per equity share
Min investment₹14,820
Issue size₹1,757 Cr
Total issue size1,77,86,442 shares(up to ₹1,757 Cr)
Fresh issue15,21,261 shares(up to ₹150 Cr)
Offer for sale (OFS)1,62,65,181 shares(up to ₹1,607 Cr)
Listing atBSE,NSE
Listing dateSep 1, 2026
RegistrarMUFG Intime India Private Limited
Lead manager(s)JM Financial Ltd., Avendus Capital Pvt.Ltd., Motilal Oswal Investment Advisors Ltd., Nomura Financial Advisory & Securities (India) Pvt.Ltd.
IPO Timeline
Timeline
Displays the complete IPO schedule, including the issue opening and closing dates, basis of allotment, refund initiation, share credit to Demat accounts, and the expected listing date on the stock exchanges.
Bidding StartsCompleted
Aug 24, 2026Bidding EndsCompleted
Aug 27, 2026Allotment Completed
Aug 28, 2026ListingIn progress
Sep 1, 2026IPO Documents
IPO Documents
Provides access to the official offer documents filed by the company with SEBI, including the RHP and DRHP.
Application Wise Breakup (Approx.)
Application Wise Breakup (Approx.)
Shows the number of applications received against the reserved category size, indicating how many times each investor category was subscribed by application count.
| Category | Reserve (Shares) | Applied (No. of Applications) | Times Folded |
|---|---|---|---|
| BNIIs (>10L) | 8,454 | 1,50,254 | 17.77x |
| SNIIs (<10L) | 4,277 | 2,37,511 | 55.53x |
| Individual | 4,14,237 | 48,46,777 | 11.7x |
Total Applications52,59,328 approx.
Grey Market Premium (GMP) History
Grey Market Premium (GMP) History
Shows the daily Grey Market Premium, estimated listing price, and estimated gains before listing.
Current GMP₹25526%
Scroll to Zoom • Double Click to Reset
Market Lot Size
IPO Lot Size
Shows the application lots, shares, and investment amount required for each IPO category.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 15 | ₹14,820 |
| Retail(max) | 13 | 195 | ₹1,92,660 |
| sHNI(min) | 14 | 210 | ₹2,07,480 |
| sHNI(max) | 67 | 1,005 | ₹9,92,940 |
| bHNI(min) | 68 | 1,020 | ₹10,07,760 |
IPO Reservation
IPO Reservation
Shows the number of shares reserved for each investor category, the percentage of the total issue allocated to each category, and the maximum number of allottees where applicable.
| Investor Category | Shares Offered | Percentage | Max Allottees |
|---|---|---|---|
| Anchor Investor Shares Offered | 53,25,909 | 29.94% | — |
| QIB Shares Offered | 35,50,608 | 19.96% | — |
| NII (HNI) Shares Offered | 26,62,955 | 14.97% | — |
| bHNI > ₹10L | 17,75,304 | 10% | 8,454 |
| sHNI < ₹10L | 8,87,652 | 5% | 4,277 |
| Retail Shares Offered | 62,13,562 | 34.93% | 4,14,237 |
| Employee Shares Offered | 33,408 | 0.19% | — |
Subscription Details (No. of Shares)
Subscription Details (No. of Shares)
Shows the subscription received from each investor category during the IPO.
| Category | Offer (Shares) | Applied (Shares) | Subscription (times) |
|---|---|---|---|
| QIBs | 35,50,608 | 64,33,59,195 | 181.2x |
| BNIIs (>10L) | 17,75,304 | 15,50,46,495 | 87.34x |
| SNIIs (<10L) | 8,87,652 | 5,14,88,625 | 58.01x |
| NIIs | 26,62,955 | 20,65,35,120 | 77.56x |
| Individual | 62,13,562 | 8,48,10,330 | 13.65x |
| Total | 1,24,60,533 | 93,52,49,700 | 75.06x |
Total Applications52,59,328 approx.
Subscription Details (In Crores)
Subscription Details (In Crores)
Shows the subscription amount received from each investor category during the IPO, expressed in ₹ Crores.
| Category | Offer | Applied | Subscription (times) |
|---|---|---|---|
| QIBs | ₹ 350.80 Cr | ₹ 63,563.89 Cr | 181.2x |
| BNIIs (>10L) | ₹ 175.40 Cr | ₹ 15,318.59 Cr | 87.34x |
| Individual | ₹ 613.90 Cr | ₹ 8,379.26 Cr | 13.65x |
| NIIs | ₹ 263.10 Cr | ₹ 20,405.67 Cr | 77.56x |
| SNIIs (<10L) | ₹ 87.70 Cr | ₹ 5,087.08 Cr | 58.01x |
| Total | ₹ 1,231.10 Cr | ₹ 92,402.67 Cr | 75.06x |
Key Performance Indicators (KPI)
Key Performance Indicators (KPI)
Shows key financial ratios used to evaluate the company's performance and financial health.
| Metric | Value |
|---|---|
| EPS (Pre IPO) | 17.82 |
| EPS (Post IPO) | 17.39 |
| P/E (Pre IPO) | 55.44x |
| P/E (Post IPO) | 56.81x |
| ROE | 11.19% |
| ROCE | 11.56% |
| RoNW | 9.48% |
| PAT Margin | 12.6% |
| Price to Book Value | 5.35x |
| Market Cap (₹ Cr) | 6244.43 |
Company Financials
Company Financials
Shows the company's financial statements across different reporting periods.
| Particulars (₹ Cr) | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 |
|---|---|---|---|
| Assets | 1,780.79 | 1,579.65 | 1,294.79 |
| Revenue | 872.26 | 755.98 | 723.33 |
| Profit After Tax | 109.90 | 96.79 | 100.06 |
| Net Worth | 1,158.64 | 821.15 | 720.68 |
| Reserves & Surplus | 1,145.95 | 810.03 | 709.54 |
| Total Borrowing | 387.91 | 540.92 | 247.21 |
About Symbiotec Pharmalab IPO
Company Contact Details
Company Contact Details
Provides the company's official contact information, including its address, email, phone number, and website.
Address
385/2, Pigdamber, Rau, Mhow, Indore, Madhya Pradesh, 453331
Phone
+91 731 667 6405
Website
http://www.symbiotec.com/IPO Registrar
IPO Registrar
Provides the contact details of the registrar handling IPO allotment and investor queries.
Registrar Name
MUFG Intime India Private Limited
Phone
+91 810 811 4949
Website
https://in.mpms.mufg.com/
Symbiotec Pharmalab IPO
ClosedMainboardGMP Price
₹255(+26%)
Subscription
82.94x
Share on
IPO Timeline
Timeline
Displays the complete IPO schedule, including the issue opening and closing dates, basis of allotment, refund initiation, share credit to Demat accounts, and the expected listing date on the stock exchanges.
Bidding StartsCompleted
Aug 24, 2026Bidding EndsCompleted
Aug 27, 2026Allotment Completed
Aug 28, 2026ListingIn progress
Sep 1, 2026IPO Documents
IPO Documents
Provides access to the official offer documents filed by the company with SEBI, including the RHP and DRHP.